In a significant move to enhance Pakistan’s pharmaceutical industry, a delegation from the Pakistan Pharmaceutical Manufacturers’ Association (PPMA), led by Chairman PPMA, held a crucial meeting with Dr. Malik Mukhtar Ahmad Bharath, Coordinator to the Prime Minister on Health. Explore more at: https://ppma.org.pk/events/meeting-of-ppma-delegate-led-by-chairman-ppma-with-coordinator-to-pm-on-health-dr-malik-mukhtar-ahmad-bharath/
Key Discussions & Highlights of the Meeting
During this high-level discussion, the PPMA delegation addressed several urgent matters affecting the pharmaceutical industry. Some of the key points included:
1. Strengthening Local Pharmaceutical Manufacturing
The PPMA emphasized the need for policies that support local drug manufacturing to reduce dependency on imports and make medicines more affordable for Pakistanis.
2. Regulatory Reforms & Faster Approvals
Industry leaders highlighted the delays in drug approvals and licensing. The delegation urged the government to streamline regulatory processes through faster approvals, simplified compliance procedures, and digitalized documentation.
3. Price Control & Economic Sustainability
The pharmaceutical industry is facing financial pressures due to high production costs. PPMA called for a balanced pricing policy that ensures medicines remain affordable for consumers while also allowing manufacturers to sustain operations.
4. Export Expansion & Global Market Entry
PPMA stressed the importance of boosting pharmaceutical exports and encouraged government support in achieving international certifications. This would help Pakistani pharmaceutical companies enter global markets and compete internationally.
5. Collaboration Between Pharma & Government
The meeting highlighted the need for continuous engagement between the government and the pharmaceutical industry to ensure policy decisions align with ground realities.
Outcome & Future Expectations
The discussions were positively received, and Dr. Malik Mukhtar Ahmad Bharath assured the PPMA delegation of the government’s commitment to resolving industry concerns. Steps will be taken to:
✔ Improve collaboration between pharma manufacturers and regulatory authorities.
✔ Accelerate approval processes for life-saving medicines.
✔ Develop a framework for sustainable pricing models.
✔ Support local manufacturing to reduce reliance on imports.
The meeting ended with a mutual understanding of working towards a more innovative, self-sufficient, and globally competitive pharmaceutical industry in Pakistan.
Final Thoughts – A Step Towards Pharma Industry Growth
This high-profile engagement between PPMA and the Prime Minister’s Health Coordinator is a major step forward in strengthening Pakistan’s pharmaceutical landscape. The government’s willingness to address industry concerns and implement necessary reforms offers a hopeful future for pharma businesses, healthcare professionals, and the public.
PPMA remains committed to ensuring high-quality medicines and driving industry-wide advancements through policy dialogues, innovation, and global collaborations.
📢 Stay tuned for more updates on future industry meetings and government policy changes!
🔗 Learn more about PPMA events here: PPMA Events
Author: Pakistan Pharmaceutical Manufacturer Association (PPMA)
https://ppma.org.pk/
